Chromatographic and spectroscopic methods of identification for the side-chain regioisomers of 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB

Journal of Chromatographic Science

Volumn 41, Issue 5, 2003, Pages 227-233

  Aalberg, Laura ^a,b   DeRuiter, Jack ^a   Taylor Noggle, F ^c   Sippola, Erkki ^b   Clark, C Randall ^a  

^a AUBURN UNIVERSITY   (United States)

^b National Bureau of Investigation Finland   (Finland)

^c Alabama Department of Forensic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXY N,N DIMETHYLAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; N METHYL 3,4 METHYLENEDIOXYPHENYLBUTANAMINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CHROMATOGRAPHY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SYNTHESIS; ELUTION; FORENSIC MEDICINE; ISOMERISM; MOLECULAR WEIGHT; SPECTROSCOPY; TEMPERATURE;

EID: 0037497101     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/41.5.227     Document Type: Article

References (14)

1. K.M. Hegadoren, G.B. Baker, and M. Bourin. 3,4-Methylenedioxy analogues of amphetamines: defining the risks to humans. Neurosci. Biobehav. Rev. 23: 539-53 (1999).
2. D.E. Nichols, A.J. Hoffman, R.A. Oberlender, P. Jacob, III, and A.T. Shulgin. Derivatives of 1-(1,3-benzodioxolyl)-2-butanamine: representatives of a novel therapeutic class. J. Med. Chem. 29: 2009-15 (1986).
3. J. DeRuiter, P.L. Holston, F.T. Noggle, and C.R. Clark. Liquid chromatographic and mass spectral methods of identification for the regioisomeric 2,3- and 3,4-methylenedioxyphenalkylamines. J. Chromatogr. Sci. 36: 131-38 (1998).
4. F.T. Noggle, Jr., C.R. Clark, S.V. Andurkar, and J. DeRuiter. Liquid chromatographic analysis of regioisomers and enantiomers of N-(chlorobenzyl)-β-methylphenethylamines: analogues of clobenzorex. J. Liq. Chromatogr. 13: 763-77 (1990).
5. C.R. Clark, A.K. Valaer, F.T. Noggle, and J. DeRuiter. GC-MS analysis of acylated derivatives of methamphetamine and regioiosomeric phenethylamines. J. Chromatogr. Sci. 33: 485-92 (1995).
6. W.H. Soine, R.E. Shark, and D.T. Agee. Differentiation of 2,3-methylenedioxy-amphetamine from 3,4-methylenedioxyamphetamine. J. Forensic Sci. 28: 386-90 (1983).
7. J. DeRuiter, P. Holston, F.T. Noggle, and C.R. Clark. Liquid chromatographic and mass spectral methods of identification for the regioisomeric dimethoxyamphetamines and brominated dimethoxyamphetamines. J. Chromatogr. Sci. 36: 73-79 (1998).
8. C.R. Clark, F.T. Noggle, and J. DeRuiter. Chromatographic and mass spectrometric methods for the differentiation of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine from regioisomeric derivatives. J. Chromatogr. Sci. 34: 230-37 (1996).
9. S. Freeman and J.F. Alder. Arylethylamine psychotropic recreational drugs: a chemical perspective. Eur. J. Med. Chem. 37: 527-39 (2002).
10. L. Aalberg, J. DeRuiter, F.T. Noggle, E. Sippola, and C.R. Clark. Chromatographic and mass spectral methods of identification for the side-chain and ring regioisomers of methylenedioxymethamphetamine. J. Chromatogr. Sci. 38: 329-37 (2000).
11. J. DeRuiter, C.R. Clark, and F.T. Noggle. GC-MS and HPLC analysis of bromination products of the regioisomeric dimethoxyphenethylamines: differentiation of "Nexus" from five positional isomers. J. Chromatogr. Sci. 36: 23-28 (1998).
12. F.T. Noggle, C.R. Clark, A.K. Valaer, and J. DeRuiter. Liquid chromatographic and mass spectral analysis of N-substituted analogues of 3,4-methylenedioxyamphetamine. J. Chromatogr. Sci. 26: 410-15 (1988).
13. C.R. Clark, J. DeRuiter, A.K. Valaer, and F.T. Noggle. Gas chromatographic-mass spectrometric and liquid chromatographic analysis of designer butanamines related to MDMA. J. Chromatogr. Sci. 33: 328-37 (1995).
14. C.A. Cramers, H.G. Janssen, M.M. van Deursen, and P.A. Leclercq. High-speed gas chromatography: an overview of various concepts. J. Chromatogr. A 856: 315-29 (1999).